Cancer cells possess a unique ability to alter their metabolic pathways, enabling them to thrive in tumultuous environments. This phenomenon, termed metabolic reprogramming, represents a crucial driver in cancer development and progression. Consequently, targeting these altered metabolic pathways presents a promising avenue for novel cancer therapi… Read More